Emerging nanotechnology approaches for HIV/AIDS treatment and prevention
- PMID: 20148638
- PMCID: PMC2861897
- DOI: 10.2217/nnm.10.1
Emerging nanotechnology approaches for HIV/AIDS treatment and prevention
Abstract
Currently, there is no cure and no preventive vaccine for HIV/AIDS. Combination antiretroviral therapy has dramatically improved treatment, but it has to be taken for a lifetime, has major side effects and is ineffective in patients in whom the virus develops resistance. Nanotechnology is an emerging multidisciplinary field that is revolutionizing medicine in the 21st century. It has a vast potential to radically advance the treatment and prevention of HIV/AIDS. In this review, we discuss the challenges with the current treatment of the disease and shed light on the remarkable potential of nanotechnology to provide more effective treatment and prevention for HIV/AIDS by advancing antiretroviral therapy, gene therapy, immunotherapy, vaccinology and microbicides.
Figures


References
-
- Blattner W, Gallo RC, Temin HM. HIV causes AIDS. Science. 1988;241(4865):515–516. - PubMed
-
- Gallo RC. Historical essay. The early years of HIV/AIDS. Science. 2002;298(5599):1728–1730. - PubMed
-
- Gallo RC, Montagnier L. The discovery of HIV as the cause of AIDS. N Engl J Med. 2003;349(24):2283–2285. - PubMed
-
- Montagnier L. Historical essay. A history of HIV discovery. Science. 2002;298(5599):1727–1728. - PubMed
-
- Furin JJ, Behforouz HL, Shin SS, et al. Expanding global HIV treatment: Case studies from the field. Ann NY Acad Sci. 2008;1136:12–20. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical